ICS 2023 Scientific Podium Short Oral Session S17

ICS Members Only

Become an ICS Member today to watch

Join ICS Sign in

{{CC.VideoPaywalButtonText}} Sign in Sign in

Restricted Video

Sign in to watch

You do not have permission to view this video

ICS members can access all the meeting webcasts

Sign in Join Now

ICS Members Only Restricted Video

Speakers
	Scientific Podium Short Oral Session S17
	Thursday 28th September 2023
	10:30 - 12:00
	Room 104AB Capacity: 320
	Lunch provided
	Recorded for Gold Pass attendees Find out more
M May Sanaee ICS Chair P Patricia Lee ICS Chair
Professional interest
Urogynaecology and Female & Functional Urology

10:30

#125 Complications of Obliterative versus Reconstructive Vaginal Surgery for Pelvic Organ Prolapse in Octogenarians

Presenter: Charlotte Elizabeth Mahon Coleman

Coleman C¹, Bonasia K¹, Pascali D¹, Clancy A¹
1. Department of Obstetrics, Gynecology and Newborn Care, The Ottawa Hospital, Ottawa, ON
Gerontology, Pelvic Organ Prolapse, Surgery, Retrospective Study, Infection, Urinary Tract

10:45

#127 Biomechanical and Immunobiological Properties of Human Fascia Lata (HFL) vs Mesh: Implications for Pelvic Reconstructive Surgery

Presenter: David Hennes

Hennes D¹, Darzi S¹, Paul K¹, Buckley V², Carey M², Gargett C¹, Werkmeister J¹, Rosamilia A², Mukherjee S¹
1. Hudson Institute of Medical Research, 2. Monash Health
Grafts: Biological, Robotic-assisted genitourinary reconstruction, Stem Cells / Tissue Engineering, Pelvic Organ Prolapse, Surgery

10:52

#128 Vaginal mesh exposures after colposacropexy:a good learining curve is the only tip and tricks to avoid it

Presenter: Ester Illiano

Costantini E¹, Illiano E²
1. Andrological and urogynecological Clnic,Santa Maria Terni Hospital,University of Perugia, 2. Andrological and urogynecological Clnic,Santa Maria Terni Hospital,University of Perugia
Prolapse Symptoms, Robotic-assisted genitourinary reconstruction, Retrospective Study, Surgery

11:00

#129 Quality of sexual life after pelvic organ prolapse surgery

Presenter: Olga Wihersaari

Wihersaari O¹, Karjalainen P¹, Tolppanen A², Mattsson N³, Nieminen K⁴, Jalkanen J⁵
1. Department of Obstetrics and Gynecology, Hospital Nova of Central Finland, Jyväskylä, Finland., 2. School of Pharmacy, University of Eastern Finland, Kuopio, Finland., 3. Aava Medical Center, Hämeenlinna, Finland., 4. Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland., 5. Central Finland Hospital District, Jyväskylä, Finland.
Pelvic Organ Prolapse, Sexual Dysfunction , Surgery, Quality of Life (QoL), Prospective Study

11:07

#130 Interventions for treating obstetric fistula: results of an evidence gap map

Presenter: Eugenie Evelynne Johnson

Johnson E¹, O'Connor N¹, Hilton P², Goh J³, Vale L⁴, Pearson F¹
1. Population Health Sciences Institute/NIHR Innovation Observatory, Newcastle University, UK, 2. c/o Population Health Sciences Institute, Newcastle University, UK, 3. School of Medicine, Griffith University, Australia, 4. Population Health Sciences Institute, Newcastle University, UK
Female, Fistulas, Conservative Treatment, Surgery

11:15

#131 Prevalence and repair patterns of vesicovaginal fistula: A large retrospective population-based cohort analysis

Presenter: Sarah Neu

Neu S¹, Locke J¹, Zhang B², Saskin R², Herschorn S¹
1. University of Toronto, 2. ICES
Fistulas, Female, Incontinence, Surgery

11:22

#132 Retrospective analysis of 3a OASI repairs in a teaching hospital: Subjective and objective outcomes

Presenter: Joy Alawale

Alawale J¹, Bulchandani S¹
1. University Hospitals Coventry and Warwickshire
Anal Incontinence, Female, Imaging

11:30

#133 Manchester procedure in women with levator ani muscle avulsions: effect on long term anatomical and patient-reported outcomes

Presenter: Sissel Hegdahl Oversand

Oversand S¹, Volløyhaug I², Staff A³, Svenningsen R³
1. Oslo University Hospital, 2. Trondheim University Hospital/ Norwegian University of Science and Technology, 3. Oslo University Hospital/ University of Oslo
Prospective Study, Pelvic Organ Prolapse, Anatomy, Pelvic Floor, Sexual Dysfunction

11:37

#134 Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women: a Cochrane systematic review

Presenter: Eugenie Evelynne Johnson

Johnson E¹, Taithongchai A², Ismail S³, Barron-Millar E¹, Thakar R⁴
1. Population Health Sciences Institute/NIHR Innovation Observatory, Newcastle University, UK, 2. Department of Obstetrics and Gynaecology, King's College Hospital, UK, 3. Department of Obstetrics and Gynaecology, Royal Sussex County Hospital, UK, 4. Department of Obstetrics and Gynaecology, Croydon University Hospital NHS Trust, UK
Pelvic Organ Prolapse, Prolapse Symptoms, Female

11:45

#135 Evaluation of symptom onset of overactive bladder associated with pelvic organ prolapse as a predictor of postoperative improvement

Presenter: Hikaru Tomoe

Tomoe H¹
1. Tokyo Women's Medical University, Adachi Medical Center
Overactive Bladder, Pelvic Organ Prolapse, Bladder Outlet Obstruction , Surgery

11:52

#136 Estimated National Cost of Pelvic Organ Prolapse Surgery in the United States

Presenter: Brad St. Martin

St. Martin B¹, Markowitz M¹, Lundsberg L¹, Myers E², Ringel N¹
1. Yale School of Medicine, 2. Duke University Medical Center
Pelvic Organ Prolapse, Surgery, Outcomes Research Methods

Content Visitors (staff only)

Prolapse and Fistula

ICS Members Only

ICS Members Only

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

Restricted Video

Restricted Video

Session Schedule

Prolapse and Fistula

ICS Members Only

ICS Members Only

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

Restricted Video

Restricted Video

ICS Members Only Restricted Video

Session Schedule

Comments

Chat